Funding Details
- Awarder
- Inbox
- Date Award
- January 13, 2025
- Vertical
- Nanomedicine
- Funding URL
- View Funding Page
Company Info
- Traction
- Funding will enable completion of ongoing Phase 2 ophthalmology trial and Phase 1/2 neuroinflammation trial.
- Company Description
- Ashvattha Therapeutics is a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in regions of inflammation.
- Market
- Ophthalmology and Neuroinflammation
- Location
-
Redwood City,
California,
USA
- Coinvestors
- Tribe Capital, Natural Capital
Links